logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
K

Karen Yee

University Health Network
H指数:45
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis

CPX-351治疗继发性急性髓系白血病的真实世界经验：与FLAG-IDA的倾向性评分匹配分析

BRITISH JOURNAL OF HAEMATOLOGY
IF3.8
2025-12-010
OAAI
Perusini, Maria Agustina; Patino, Ana Flavia; Andrews, Claire; Assouline, Sarit E.; Brandwein, Joseph M.; Chow, Signy; Popradi, Gizelle; Sanford, David; Savoie, Lynn; Saini, Lalit; Nadia, Bambace; Khalaf, Dina; Schuh, Andre C.; Yee, Karen; Gupta, Vikas; Maze, Dawn; Chan, Steven M.; Schimmer, Aaron D.; Sabry, Waleed; Sibai, Hassan
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort

Olutasidenib治疗IDH1突变急性髓系白血病: 2期关键队列的最终五年结果

Journal of Hematology & Oncology
IF40.4
2025-11-170
OAAI
Jorge Cortes; Antonio Curti; Pierre Fenaux; Brian A. Jonas; Jürgen Krauter; Pau Montesinos; Christian Récher; David C. Taussig; Eunice S. Wang; Justin Watts; Andrew Wei; Karen WL Yee; Hua Tian; Aaron Sheppard; Christophe Marzac; Stephane de Botton
Decitabine-cedazuridine in patients with MDS and TP53 mutations

地西他滨-西达佐鲁定在伴TP53突变的患者中的研究

Blood Advances
IF7.1
2025-11-140
OAAI
Samuel Urrutia; Koji Sasaki; Alex Bataller; Hagop Kantarjian; Guillermo Montalban-Bravo; James McCloskey; Elizabeth A. Griffiths; Karen Yee; Amer Zeidan; Michael Savona; Aram Oganesian; Yuri Sano; Harold N. Keer; Guillermo García-Manero
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial

enasidenib联合venetoclax在IDH2突变型复发或难治性急性髓系白血病或骨髓增生异常综合征患者中的疗效研究（ENAVEN-AML）：一项多中心、单臂、1b/2期临床试验

The Lancet Haematology
IF0
2025-10-080
PRE
Guillaume Richard-Carpentier; Gopila Gupta; Charina Koraksic; Severine Cathelin; Lisa Wang; Aniket Bankar; Marta Davidson; Vikas Gupta; Dawn Maze; Mark D Minden; Tracy Murphy; Aaron D Schimmer; Andre C Schuh; Hassan Sibai; Karen Yee; Courtney D DiNardo; Joseph Brandwein; Caroline J McNamara; Steven M Chan
Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis

谁真正能从吉特里替尼联合治疗中获益：FLT3突变复发难治(R/R)急性髓系白血病(AML)的加拿大单中心分析

Blood Cancer Journal
IF11.6
2025-08-260
OAAI
Akhil Rajendra; Elliot Smith; Maria Agustina Perusini; Kenny Tang; Eshetu G. Atenafu; Aniket Bankar; Steven Chan; Marta B. Davidson; Vikas Gupta; Dawn Maze; Mark D. Minden; Guillaume Richard-Carpentier; Aaron D. Schimmer; Andre C. Schuh; Karen Yee; Hassan Sibai
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry

骨髓增生异常综合征患者感染并发症的评估: 来自加拿大MDS登记处的前瞻性队列研究

ANNALS OF HEMATOLOGY
IF2.4
2024-11-220
PRE
Mathur, S.; Christou, G.; Delage, R.; Elemary, M.; Finn, N.; Geddes, M.; Houston, D. S.; Keating, M. M.; Khalaf, D.; Leber, B.; Leitch, H.; Lother, S. A.; Mozessohn, L.; Nevill, T.; Parmentier, A.; Paulson, K.; Rimmer, E.; Sabloff, M.; Shamy, A.; St-Hilaire, E.; Storring, J.; Yee, K.; Zhang, L.; Zhu, N.; Hay, A. E.; Zarychanski, R.; Buckstein, R.; Houston, Brett L.
FLAG-IDA Plus Venetoclax in High-Risk Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia: The Princess Margaret Cancer Center Experience

FLAG-IDA Plus Venetoclax 在高风险初诊及复发或难治性急性髓系白血病中的疗效：玛格丽特公主癌症中心的经验

BLOOD
IF23.1
2024-11-050
PRE
Al-Shaibani, Eshrak; Davidson, Marta Beata; Bankar, Aniket; Chan, Steven M.; Sibai, Hassan; Maze, Dawn C.; Schimmer, Aaron; Minden, Mark D.; Yee, Karen; Gupta, Vikas; Schuh, Andre C.; Richard-Carpentier, Guillaume
Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial
BLOOD ADVANCES
IF7.1
2024-04-232
OAAI
Roboz, Gail J.; Sanz, Guillermo; Griffiths, Elizabeth A.; Yee, Karen; Kantarjian, Hagop; Recher, Christian; Byrne, Michael T.; Patkowska, Elzbieta; Kim, Hee-Je; Thomas, Xavier; Moors, Ine; Stock, Wendy; Illes, Arpad; Fenaux, Pierre; Miyazaki, Yasushi; Yamauchi, Takahiro; O'Connell, Casey L.; Hao, Yong; Keer, Harold N.; Azab, Mohammad; Doehner, Hartmut
Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN

在加速和爆炸阶段MPN中强化和非强化爆炸减少策略的结果

BLOOD ADVANCES
IF7.1
2024-03-043
OAAI
Davidson, Marta B.; Kennedy, James A.; Capo-Chichi, Jose-Mario; Shi, Yuliang; Xu, Wei; Cheung, Verna; Arruda, Andrea; Ankar, Aniket B.; Richard-Carpentier, Guillaume; Chan, Steven; Maze, Dawn; Minden, Mark D.; Schimmer, Aaron D.; Schuh, Andre C.; Sibai, Hassan; Yee, Karen; Tierens, Anne; Viswabandya, Auro; Gupta, Vikas
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
LANCET HAEMATOLOGY
IF17.7
2024-01-0115
PRE
Garcia-Manero, Guillermo; McCloskey, James; Griffiths, Elizabeth A.; Yee, Karen W. L.; Zeidan, Amer M.; Al-Kali, Aref; Deeg, H. Joachim; Patel, Prapti A.; Sabloff, Mitchell; Keating, Mary-Margaret; Zhu, Nancy; Gabrail, Nashat Y.; Fazal, Salman; Maly, Joseph; Odenike, Olatoyosi; Kantarjian, Hagop; DeZern, Amy E.; O'Connell, Casey L.; Roboz, Gail J.; Busque, Lambert; Buckstein, Rena; Amin, Harshad; Randhawa, Jasleen; Leber, Brian; Shastri, Aditi; Dao, Kim-Hien; Oganesian, Aram; Hao, Yong; Keer, Harold N.; Azab, Mohammad; Savona, Michael R.

研究方向

暂未获取到该数据
A
Andre C. Schuh
H 指数:46论文数:368被引数:1.7万
M
Mark D. Minden
H 指数:92论文数:1,259被引数:4.4万
V
Vikas Gupta
H 指数:75论文数:896被引数:2.4万
H
Hassan Sibai
H 指数:16论文数:176被引数:941
D
Dawn Maze
H 指数:15论文数:151被引数:905
A
Aaron D. Schimmer
H 指数:0论文数:5被引数:0
J
Joseph Brandwein
H 指数:52论文数:330被引数:1.2万
S
Steven M. Chan
H 指数:31论文数:311被引数:6,340
A
Aaron D. Schimmer
H 指数:76论文数:780被引数:2.1万
S
Suzanne Kamel‐Reid
H 指数:67论文数:437被引数:1.9万